Generated by AI
Edap Tms S.A. is a leading company in the medical device industry, specializing in the development and commercialization of therapeutic ultrasound solutions. The firm's primary purpose is to advance treatments in urology, oncology, and other critical medical fields through minimally invasive technologies. As a pioneer in the field, Edap Tms S.A. focuses on high-intensity focused ultrasound (HIFU) technology, aiming to provide alternatives to traditional surgical procedures. This enables medical professionals to target tissues with precision, potentially reducing recovery times and improving patient outcomes. The company's products notably impact the healthcare sector, offering innovative solutions in addressing prostate cancer and kidney stones, among other conditions. Globally, Edap Tms S.A. plays a significant role in the evolution of medical treatments by incorporating advanced ultrasound techniques, which appeal to healthcare providers seeking effective, patient-centric solutions. Founded in Lyon, France, and with a presence in numerous international markets, Edap Tms S.A. remains at the forefront of medical innovation.
WebsiteParc d’Activites la Poudrette-Lamartine
Vaulx-en-Velin, 69120
France
The latest articles about EDAP.
FocalTherics™ to Participate in Upcoming Investor ConferencesAUSTIN, Texas, Nov. 04, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the “...
Summary of May 7's posts. Generated by AI.
Summary of Jul 25's posts. Generated by AI.
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026Company to host conference call and webcast on Thursday, Novembe...
Summary of Sep 26's posts. Generated by AI.
Investors talking about EDAP also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.